(Downloading may take up to 30 seconds.
If the slide opens in your browser, select File -> Save As to save it.)
Click on image to view larger version.

Fig. 2. SHP-2 regulates Spry phosphorylation. (A) FGF signaling
pathway with Spry feedback loop. FGF activates Spry feedback by inducing
spry expression (broken line) and stimulating tyrosine
phosphorylation of Spry to generate Spry-P. Circled numbers indicate steps by
which SHP-2/Csw could promote to increase signal output. (B) Effect of
SHP-2 on Spry1 tyrosine phosphorylation. HEK293 cells were transfected with
expression constructs for HA-Spry1, FGFR1c and either empty vector or
expression constructs for dominant-negative SHP-2C459S or wild-type
SHP-2 as indicated. Transfected cells were left untreated (lanes 1-3) or
treated with bFGF (lanes 4-6). (Top) Immunoprecipitated HA-Spry1 analyzed on
immunoblot with anti-phosphotyrosine antiserum. SHP-2C459S
increased HA-Spry1 phosphorylation (lane 5) and SHP-2 reduced it (lane 6).
(Middle) Immunoblot reprobed with anti-HA to show total HA-Spry1. (Bottom)
Immunoblot of whole cell lysates probed with anti-SHP-2. Similar results were
obtained in two experiments. (C) Specificity of phospho-specific Spry1
antiserum. HEK293 cells were transfected with expression plasmids for FGFR1c
and HA-Spry1 or HA-Spry1Y53F as indicated. Transfected cells were
treated with bFGF for times indicated, and HA-Spry1 was immunoprecipitated and
analyzed on immunoblots probed with
-pY53 antiserum (top) or anti-HA to
show total HA-Spry1 (bottom). (D) Effect of SHP-2C459S on
Spry1 Y53 phosphorylation. HEK293 cells were transfected with plasmids
expressing FGFR1c and HA-Spry1, and empty vector or vector expressing
dominant-negative SHP-2C459S as indicated. Transfected cells were
left untreated (lanes 1,2) or treated with bFGF for 60 minutes (lanes 3,4).
(Top) Immunoblot of immunoprecipitated HA-Spry1 probed with
-pY53.
SHP-2C459S increased phosphorylation on pY53. (Middle) Control
immunoblot probed with anti-HA. (Bottom) Immunoblot of whole cell lysates
probed with anti-SHP-2. Similar results were obtained in two experiments.
(E) Effect of SHP-2C459S on other Spry1 phosphotyrosines.
HEK293 cells were transfected with plasmids expressing FGFR1c and either empty
vector or vector expressing dominant-negative SHP-2C459S as
indicated, and plasmids expressing HA-Spry1 (WT, lanes 1,2),
HA-Spry1Y53F (lanes 3, 4), HA-Spry1Y89F (lanes 5, 6), or
HA-Spry1Y53F, Y89F (lanes 7, 8). FGF treatment and subsequent
analysis with anti-phosphotyrosine antiserum was as in lanes 4 and 5 (of B).
SHP-2C459S influenced tyrosine phosphorylation on HA-Spry1 when Y53
was altered (lanes 3,4), indicating that SHP-2 also affects other tyrosine(s),
notably Y89 (lanes 5-8). Similar results were obtained in three
experiments.